Laurence J. Heifetz, MD, FACP, medical director, Gene Upshaw Memorial Tahoe Forest Cancer Center, discusses a novel approach to managing disparities in lung cancer care.
Laurence J. Heifetz, MD, FACP, medical director, Gene Upshaw Memorial Tahoe Forest Cancer Center, discusses a novel approach to managing disparities in lung cancer care.
Approximately 20% of Americans live in rural areas, which means they have less access to state-of-the-art medical care, specifically cancer care, says Heifetz. This means these patients will also get a delay in optimal care.
The Gene Upshaw Memorial Tahoe Forest Cancer Center put together a system addressing the 4 major malignancies that comprise 80% of all cancers, which are breast cancer, lung cancer, gastrointestinal cancer, and genitourinary cancer. The center partnered with the University of California, Davis Comprehensive Cancer Center to be a part of their network, which has 4 remote facilities.
Every week, virtual tumor boards are conducted in each of these 4 malignancies for community physicians to gain insight from academic oncologists on patient cases, recent clinical data, and more. These tumor boards became the culture definer for this program, Heifetz concludes.
Emphasizing the Need for NGS in Advanced NSCLC to Determine Treatment
April 23rd 2024During a Case-Based Roundtable® event, Joshua Sabari, MD, led a discussion on the need for next-generation sequencing to determine treatment in patients with EGFR-positive advanced non–small cell lung cancer in the first article of a 2-part series.
Read More
Biomarker Testing Paves the Way for Better Targeted Therapies in NSCLC
April 16th 2024At a live virtual event, Edward S. Kim, MD, MBA, discussed the evolving landscape of biomarker testing before making treatment decisions for patients with early-stage non–small cell lung cancer (NSCLC).
Read More